Targeted Medical Pharma, Inc. 4/A

Accession 0001144204-13-049193

CIK 0001420030operating

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 1:59 PM ET

Size

9.0 KB

Accession

0001144204-13-049193

Form 4/AAmended

Period: 2013-04-16

10% Owner

Transactions

Purchase
Common Stock, $.001 par value per share
2013-06-20$1.15/sh+28,100$32,315→ 651,054 total(indirect: By Trust)

Holdings

DirectorCEO/Chief Scientific Officer10% Owner

Transactions

Purchase
Common Stock, $.001 par value per share
2013-06-20$1.15/sh+28,100$32,315→ 651,054 total(indirect: By Trust)

Holdings

Footnotes (3)

[F1]Common stock and warrants are held by Willliam Shell Survivor's Trust.
[F2]On July 23, 2013, the reporting person mistakenly filed a Form 4 without including his purchase of 28,100 shares of Targeted Medical Pharma, Inc. Such purchase occurred on June 20, 2013 at a weighted average price of $1.15 per share. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.20 per share.
[F3]See Remarks

Documents

1 file

Targeted Medical Pharma, Inc.

CIK 0001420030

Entity typeoperating